Even with inflation data coming in hotter-than-expected, investors would likely be looking for the most active stocks today. Should this be the case, biotech stocks would make for a viable option in the stock market now.
For the most part, this would be the case as the industry continues to churn out new developmental pipeline updates. The likes of which can act as catalysts for the top biotech stocks around. For one thing, companies gaining momentum from regulatory updates could draw attention as markets react to the latest inflation figures.
This post appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.